Dopamine's role in Parkinson’s disease was always misunderstood, says new study

Parkinson’s disease, which affects movement, balance and coordination, is defined by the loss of dopamine-producing brain cells (Image: Canva)

Dopamine, for years, has been described as the brain’s accelerator: Press it, and movement speeds up. Ease off, and the body slows. However, a recent research suggests dopamine’s role in movement has been misunderstood all along.

Researchers at McGill University now suggest dopamine isn’t telling the body how fast or forcefully to move. Instead, it’s making movement possible in the first place.

What is Parkinson's Disease?

Parkinson’s disease, which affects movement, balance and coordination, is defined by the loss of dopamine-producing brain cells. The drug levodopa has long been known to restore movement remarkably well, yet scientists never fully agreed on why. Many assumed dopamine surged during movement, acting like a moment-by-moment controller. With new tools able to track brain chemistry in real time, those assumptions finally faced a proper test, and they didn’t hold up.

Also read | Parkinson disease: Causes, symptoms and treatment strategies for this neurological disorder

Using advanced light-based techniques, scientists observed dopamine activity in mice as they performed physical tasks. When dopamine-producing cells were switched on or off during movement, nothing changed. Speed stayed the same. Strength stayed the same. Movement didn’t falter.

But when overall dopamine levels were restored to normal, movement improved. The implication showed that dopamine isn’t directing movement, it’s enabling it.

The researchers describe dopamine less like a throttle and more like engine oil. Oil doesn’t decide how fast a car goes, but without it, nothing runs smoothly, or at all. In the same way, dopamine creates the conditions needed for movement, without dictating its details.

This shift in thinking could simplify how doctors approach care. Instead of trying to replicate rapid dopamine bursts, future treatments may focus on maintaining steady, healthy dopamine levels, potentially reducing side effects and improving long-term outcomes.

Also read | How exercise therapy empowers people with Parkinson’s disease

What the study reveals

Dopamine does not control movement, speed, or force.

Short dopamine bursts during movement isn’t  essential.

Restoring baseline dopamine improves movement

Levodopa works by raising overall dopamine levels

Future treatments may aim for stability, not spikes

With Parkinson’s cases expected to rise as populations age, understanding how treatments work has never mattered more. This discovery invites scientists to revisit older therapies with fresh eyes, and new precision.

Disclaimer: This article, including health and fitness advice, only provides generic information. Don’t treat it as a substitute for qualified medical opinion. Always consult a specialist for specific health diagnosis.